CHEMED CORPORATION (CHE)

Every figure this model derived for CHE, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 66,346,000 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 40,222,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 291,235,000 AssetsCurrent 2026-06-30
current liabilities 319,846,000 LiabilitiesCurrent 2026-06-30
equity 830,510,000 StockholdersEquity 2026-06-30
interest expense 3,279,000 InterestExpense 2026-06-30
ocf 389,954,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 2,595,001,000 Revenues 2026-06-30
sbc 38,680,000 AllocatedShareBasedCompensationExpense 2025-12-31

The ratios

The figures themselves rather than their scores — what somebody looking up CHE on one particular measure came for.

RatioValue
cash operating margin17.51
current ratio0.91
current ratio reported0.91
dilution pct-4.78
ebit cagr0.47
ebit yoy-5.34
fcf margin12.47
growth cv0.65
interest cover106.49
net debt ebitda0.24
operating margin13.46
owner earnings margin10.98
revenue growth3.31
revenue growth per share8.5
roic29.65
rule of 4016.76
sbc pct revenue1.49

What to be careful about

What this model itself distrusts about CHE's figures. Written by the derivation as it ran, not added afterwards.